Impact News +++ Syndax Pharmaceuticals auf der Stifel 2025: Strategisches Wachstum in der Onkologie (Investing.com DE) +++ SYNDAX Aktie -4,20%

BAVARIAN NORDIC Aktie

>BAVARIAN NORDIC Aktienkurs

24.9 EUR -1.7% (Tradegate)

Ask: 25.16 EUR / 120 Stück

Bid: 24.92 EUR / 120 Stück

Tagesumsatz: 2220 Stück

Realtime Kurs von 7:30 bis 22 Uhr!

Aktie über LYNX handeln

Intraday

1 Jahr

>BAVARIAN NORDIC Performance

1 Woche: -19,1%

1 Monat: -17,9%

3 Monate: -19,7%

6 Monate: +12,1%

1 Jahr: -6,1%

laufendes Jahr: +0,1%

>BAVARIAN NORDIC Aktie

Name:

BAVARIAN NORDIC

Land:

Dänemark

Sektor:

Gesundheit

ISIN/ Wkn:

DK0015998017 / 917165

Symbol/ Ticker:

BV3 (Frankfurt)

Kürzel:

FRA:BV3, ETR:BV3, BV3:GR

Index:

Webseite:

https://www.bavarian-nord..

Profil:

Bavarian Nordic A/S is a biotechnology and pharmac..
>Volltext..

Marktkapitalisierung:

1990.15 Mio. EUR

Unternehmenswert:

1786.74 Mio. EUR

Umsatz:

876 Mio. EUR

EBITDA:

289.55 Mio. EUR

Nettogewinn:

192.58 Mio. EUR

Gewinn je Aktie:

2.46 EUR

Schulden:

18.42 Mio. EUR

Liquide Mittel:

165.24 Mio. EUR

Operativer Cashflow:

239.16 Mio. EUR

Bargeldquote:

1.01

Umsatzwachstum:

6.46%

Gewinnwachstum:

101.02%

Dividende je Aktie:

Dividendenrendite:

Dividendenschätzung:

Insiderhandel:

Suchwörter:

BAVARIAN NORDIC

Letzte Datenerhebung:

13.11.25

>Kennzahlen

Aktien/ Unternehmen:

Aktien: 78.24 Mio. St.

Frei handelbar: 98.64%

Leerverk. Aktien: -

Rückkaufquote: 0.18%

Mitarbeiter: 1611

Umsatz/Mitarb.: 0.42 Mio. EUR

Analysten:

Analystenrating: Buy

Kursziel: 39.86%

Bewertung:

KGV: 10.35

KGV lG: 8.33

KUV: 2.26

KBV: 1.22

PEG-Ratio: 0.11

EV/EBITDA: 6.17

Rentabilität:

Bruttomarge: 53.22%

Gewinnmarge: 21.98%

Operative Marge: 22.38%

Managementeffizenz:

Gesamtkaprendite: 10.1%

Eigenkaprendite: 12.65%

>Peer Group

Es sind 20 Aktien bekannt.

>BAVARIAN NORDIC Chart & Kurs - Tradegate

>BAVARIAN NORDIC News

10.11.25 - 21:03	Bavarian Nordic Announces Major Shareholder Notification from Morgan Stanley (GlobeNewswire EN)
	COPENHAGEN, Denmark, November 10, 2025 – Pursuant to section 30 of the Danish Capital Markets Act, Bavarian Nordic A/S hereby announces that the Company has received notification from Morgan Stanley that they hold 4,94% of the shares and voting rights in Bavarian Nordic A/S as of November 4, 2025....

07.11.25 - 17:33	Bavarian Nordic Announces Major Shareholder Notification from Morgan Stanley (GlobeNewswire EN)
	COPENHAGEN, Denmark, November 7, 2025 – Pursuant to section 30 of the Danish Capital Markets Act, Bavarian Nordic A/S hereby announces that the Company has received notification from Morgan Stanley that they hold 5,13% of the shares and voting rights in Bavarian Nordic A/S as of October 31, 2025....

06.11.25 - 15:21	BREAKING: Übernahme von Bavarian Nordic gescheitert – Aktie crasht (Der Aktionaer)
	Die Aktionäre von Bavarian Nordic haben das Bieterkonsortium in Form von Nordic Capital und Permira abblitzen lassen. Das Investorenduo konnte trotz des zuvor erhöhten Übernahmeangebotes nicht die dafür notwendigen Stimmrechte sammeln. Die Aktie des Impfstoff-Herstellers geht darauf in die Knie und verliert rund ein Fünftel des Wertes....

06.11.25 - 15:18	Bavarian Bidders Drop Takeover Offer After Investor Pushback (Bloomberg)
	Nordic Capital and Permira dropped their takeover bid for Bavarian Nordic A/S after their sweetened offer failed to win enough investor support....

06.11.25 - 15:06	Consortium consisting of Nordic Capital and Permira announces preliminary result of the takeover offer to shareholders of Bavarian Nordic and that the Offer is withdrawn and will not be completed (GlobeNewswire EN)
	NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION...

05.11.25 - 08:33	Bavarian Nordic Announces Major Shareholder Notification from Morgan Stanley (GlobeNewswire EN)
	COPENHAGEN, Denmark, November 5, 2025 – Pursuant to section 30 of the Danish Capital Markets Act, Bavarian Nordic A/S hereby announces that the Company has received notification from Morgan Stanley that they hold 4.92% of the shares and voting rights in Bavarian Nordic A/S as of October 30, 2025....

04.11.25 - 08:33	Bavarian Nordic Announces Major Shareholder Notification from Morgan Stanley (GlobeNewswire EN)
	COPENHAGEN, Denmark, November 4, 2025 – Pursuant to section 30 of the Danish Capital Markets Act, Bavarian Nordic A/S hereby announces that the Company has received notification from Morgan Stanley that they hold 5.12% of the shares and voting rights in Bavarian Nordic A/S as of October 29, 2025....

01.11.25 - 10:39	Bavarian Nordic Provides Clarification on the HERA Framework Agreement and the Public Preparedness Business (GlobeNewswire EN)
	COPENHAGEN, Denmark, November 1, 2025 – Bavarian Nordic A/S hereby issues the following clarification regarding the Health Emergency Preparedness and Response Authority (HERA) framework agreement, announced yesterday, and the Public Preparedness business....

31.10.25 - 16:00	Bavarian Nordic Announces Major Shareholder Notification from Morgan Stanley (GlobeNewswire EN)
	COPENHAGEN, Denmark, October 31, 2025 – Pursuant to section 30 of the Danish Capital Markets Act, Bavarian Nordic A/S hereby announces that the Company has received notification from Morgan Stanley that they hold 4.99% of the shares and voting rights in Bavarian Nordic A/S as of October 27, 2025....

31.10.25 - 14:09	Bavarian Nordic shareholders are reminded of expiry of the offer period regarding the takeover offer from consortium consisting of Nordic Capital and Permira (GlobeNewswire EN)
	NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION...

31.10.25 - 09:18	Bavarian Nordic Awarded New Procurement Framework Contract by the European Commission to Strengthen Preparedness Against Smallpox and Mpox (GlobeNewswire EN)
	COPENHAGEN, Denmark, October 31, 2025 – Bavarian Nordic A/S (OMX: BAVA) announced today the award of a joint procurement contract by the European Commission, through the Health Emergency Preparedness and Response Authority (HERA), enabling the EU, its member states and additional European countries1 to purchase up to 8 million doses of the Company's MVA-BN® smallpox/mpox vaccine....

29.10.25 - 13:33	Bavarian Nordic Announces Major Shareholder Notification from Morgan Stanley (GlobeNewswire EN)
	COPENHAGEN, Denmark, October 29, 2025 – Pursuant to section 30 of the Danish Capital Markets Act, Bavarian Nordic A/S hereby announces that the Company has received notification from Morgan Stanley that they hold 5.20% of the shares and voting rights in Bavarian Nordic A/S as of October 23, 2025....

28.10.25 - 08:33	Bavarian Nordic Provides Further Support to Mpox Outbreak in Africa through Additional Donation of Vaccines (GlobeNewswire EN)
	COPENHAGEN, Denmark, October 28, 2025 – Bavarian Nordic announced today a donation of mpox vaccines to Africa CDC to support the response to the ongoing mpox outbreak in Africa....

24.10.25 - 11:54	Bavarian Nordic Takeover Standoff Turns Into Struggle for Power (Bloomberg)
	On Danish investment forums, retail shareholders in Bavarian Nordic A/S have for weeks traded messages like battlefield dispatches....

22.10.25 - 14:27	Bavarian Nordic: Platzt die Übernahme? (Der Aktionaer)
	Das Investorenduo Nordic Capital und Permira hat sich den Übernahmeprozess des europäischen Impfstoffherstellers Bavarian Nordic sicherlich einfacher vorgestellt. Nachdem die Private-Equity-Gesellschaften bereits den Übernahmepreis je Aktie nach oben gesetzt haben, müssen die Investoren den bestehenden Aktionären einen weiteren Schritt entgegenkommen....

21.10.25 - 15:12	Bavarian Bidders Cut Bar for Takeover as Investor Clash Deepens (Bloomberg)
	Nordic Capital and Permira lowered the acceptance level of their Bavarian Nordic A/S takeover bid for the second time, stepping up efforts to bypass shareholder opposition and secure the deal....

21.10.25 - 14:48	Consortium consisting of Nordic Capital and Permira lowers the minimum acceptance condition to 66 2/3% in respect of the takeover offer to the shareholders of Bavarian Nordic (GlobeNewswire EN)
	NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION...

16.10.25 - 11:51	Bavarian Nordic shares rise 2% after board reaffirms takeover recommendation (Investing.com)
	Um den gesamten Artikel unter investing.com zu lesen, klicken Sie bitte auf die Überschrift...

16.10.25 - 10:01	Bavarian Nordic Deal in Doubt as Shareholder Rejects New Offer (Bloomberg)
	Bavarian Nordic A/S's largest shareholder refused to back a sweetened takeover offer for the Danish vaccine maker, casting fresh uncertainty over the deal....

16.10.25 - 07:30	The Board of Directors maintains its recommendation in supplementary statement in respect of the improved takeover offer to the shareholders of Bavarian Nordic from the consortium led by Nordic Capital and Permira (GlobeNewswire EN)
	NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION...

>weitere News anzeigen...

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Unter jedem Stein schläft ein Skorpion. - Sub omni lapide scorpius dormit. - Macarius Hieromonachus

Partner: >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram